AFM
CASC

Anson Funds Management’s Cascadian Therapeutics, Inc. CASC Stock Holding History

Anson Funds Management’s Portfolio CASC Stock Details CASC Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
2017
Q2 		$3.65M Buy
2017
Q1 		$2.78M Buy
2016
Q4 		$988K Buy
2016
Q3 		$1.05M Sell
2016
Q2 		$847K Buy
2016
Q1 		$870K Sell
2015
Q4 		$1.84M Buy